FDAFDA recall Z-2651-2026 · Aug 5, 2026
PHILIPS MEDICAL SYSTEMS: IQon Spectral CT IQon Spectral CT Upgrades recall
Recall found
Product
IQon Spectral CT IQon Spectral CT Upgrades
Reason for recall
The clinical CT scan may not automatically trigger after the Bolus Tracking scan and may need to be triggered manually. Additional Bolus Tracking shots may occur. This may result in the clinical acquisition being inadequate for diagnosis, causing a potential for patient rescan and receiving additional radiation.
What to do
FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.
Recall details
- FDA classification
- Class II: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
- Status
- Ongoing
- Codes, lots and dates
- FCO72800812; FCO72800814 728331 728332, DI (01)00884838059542
- Quantity
- 42
- Distribution
- US Nationwide Distribution including Puerto Rico
- Recalling firm
- PHILIPS MEDICAL SYSTEMS, Cambridge, MA
- Voluntary or mandated
- FDA Mandated
- Recall started
- 2026-06-11
Source: openFDA enforcement record Z-2651-2026 · search recall number Z-2651-2026 in FDA's Enforcement Report.
Copied from the agency record without changes. Data as of Oct 22, 2026, 4:56 AM EDT. The agency notice is the final word.